BI 764532
Boehringer Ingelheim
['sclc', 'lcsm,(-blcsm)']
happy to be back at #asco2023! also very excited to present a poster (poster board 202 on sunday morning) translational work on a novel radioimmunotherapeutic agent targeting dll3 in sclc. come check it out and discuss! #lcsm 
MD PhD
Research Associate, Memorial Sloan Kettering, New York City.
Incoming Clinical Oncology Fellow, Memorial Sloan Kettering, New York City.